Resource Summary

Clinical Question:
When stopping oral anti- coagulants (like warfarin) after treatment for venous thromboembolism (VTE)^ should ASA be offered?

Bottom line:
Once warfarin treatment for unprovoked VTE is complete^ ASA (100mg daily) prevents recurrent VTE for one in 19 patients over 2.5 years with no increase in bleeding. ASA does not replace warfarin or novel anticoagulants for the initial treatment of VTE.


*** Original Documents can be found and downloaded using the link provided below ***

https://www.acfp.ca/tools-for-practice/

Publication Date: 2013-7-22
Last Updated on PCR: 2017-03-31 15:36:37